Clinical Trials List
2024-04-01 - 2030-01-31
Phase I/II
Recruiting4
ICD-10C79.00
Secondary malignant neoplasm of unspecified kidney and renal pelvis
ICD-10C79.01
Secondary malignant neoplasm of right kidney and renal pelvis
ICD-10C79.02
Secondary malignant neoplasm of left kidney and renal pelvis
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9198.0
Secondary malignant neoplasm of kidney
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 顏志傑 無
- 鍾秉軒 無
- Shang-Yin Wu 無
- 劉奕廷 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yung-Chang Lin 無
- 黃文冠 無
- 陳安欣 無
- Hung-Chih Hsu 無
- Chan-Keng Yang 無
- Wen-Chi Shen 無
- Jen-Shi Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 徐偉勛 無
- YEN-SHEN LU 無
- Kun-Huei Yeh Division of Hematology & Oncology
- 張端瑩 無
- 吳宗哲 無
- Wei-Wu Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
9-12 participants
-
Global
178 participants
